Major Adverse Cardiovascular Event Risk According to Individual CKM Syndrome Components: A UK Biobank Study

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/39e4ed75fed86b2f79a6dacf6b364dab.pdf
Major Adverse Cardiovascular Event Risk According to Individual CKM Syndrome Components: A UK Biobank Study

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Hae-Ryong
Yun
Hae-Ryong Yun siberian82@yuhs.ac Yonsei university college of medicine internal medicine Seoul Korea (Republic of) *
Tae-Hyun Yoo YOOSY0316@yuhs.ac Yonsei university college of medicine internal medicine Seoul Korea (Republic of) -
Dae Suk Han DSHAN@yuhs.ac Yonsei university college of medicine internal medicine Seoul Korea (Republic of) -
-
-
-
-
-
-
-
-
-
-
-
-

Cardio-Kidney-Metabolic (CKM) syndrome represents a constellation of interconnected metabolic and renal abnormalities, including hypertension, diabetes, dyslipidemia, and chronic kidney disease (CKD), all of which contribute to increased cardiovascular disease (CVD) risk. While CKM syndrome has been proposed as a holistic framework for risk stratification, the relative impact of each individual component on major adverse cardiovascular events (MACEs) has not been well defined.

We analyzed data from 181,691 participants in the UK Biobank without overlapping metabolic abnormalities, selecting those with only one of the four CKM components: hypertension, type 2 diabetes mellitus (T2DM), dyslipidemia, or CKD. Individuals with multiple CKM components were excluded to isolate the independent association of each factor. Incident MACE was defined as a composite of myocardial infarction, stroke, heart failure, or cardiovascular death. Cox proportional hazards models were used to estimate hazard ratios (HRs) for MACE, adjusting for age, sex, race, smoking status, alcohol consumption, household income, and physical activity (METs). Bonferroni-adjusted pairwise comparisons were performed to examine relative risk differences between CKM components.

During 2,016,204 person-years of follow-up, 26,263 MACE events occurred. The incidence rates per 1,000 person-years were 17.9, 9.4, 9.4, 8.2, and 6.3 for hypertension, diabetes, dyslipidemia, CKD, and the reference group with no components, respectively, with hypertension showing the highest incidence rate. In adjusted models, hypertension conferred the highest risk (HR 1.69, 95% CI 1.62–1.77), followed by CKD (HR 1.24), dyslipidemia (HR 1.21), and diabetes (HR 1.17). Bonferroni contrasts confirmed hypertension’s significantly greater risk compared to the others (p < 0.001), while risk differences among the remaining components were not statistically significant.

Hypertension emerged as the strongest individual driver of MACEs among CKM components. These findings support the prioritization of blood pressure control in CVD prevention strategies targeting CKM populations.

Kewords